|
gptkbp:instanceOf
|
gptkb:Association
|
|
gptkbp:collaboratesWith
|
Healthcare_Providers
|
|
gptkbp:employs
|
Pharmaceutical Scientists
|
|
gptkbp:engagesIn
|
Clinical Trials
|
|
gptkbp:focusesOn
|
Healthcare
|
|
gptkbp:hasAccreditation
|
gptkb:Gavis_Pharmaceuticals
|
|
gptkbp:hasHistoricalSignificance
|
gptkb:Mumbai
|
|
gptkbp:hasMember
|
gptkb:Lupin_Pharmaceuticals
|
|
gptkbp:hasPart
|
gptkb:Lupin_Switzerland
gptkb:Lupin_Belgium
gptkb:Lupin_Europe
gptkb:Lupin_Japan
gptkb:Lupin_India
gptkb:Lupin_Biotech
gptkb:Lupin_Germany
gptkb:Lupin_Italy
gptkb:Lupin_Brazil
gptkb:Lupin_Canada
gptkb:Lupin_South_Africa
gptkb:Lupin_Philippines
gptkb:Lupin_Vietnam
gptkb:Lupin_Portugal
gptkb:Lupin_Ireland
gptkb:Lupin_China
gptkb:Lupin_France
gptkb:Lupin_Australia
gptkb:Lupin_Singapore
Lupin Indonesia
Lupin Middle East
Lupin New Zealand
Lupin USA
Lupin_Mexico
Lupin_Russia
Lupin_Spain
Lupin_Thailand
|
|
gptkbp:hasResidence
|
$2.5 billion
|
|
gptkbp:hasSubsidiary
|
gptkb:Lupin_Limited
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Lupin Global Network
|
|
gptkbp:isActiveIn
|
Global_Markets
|
|
gptkbp:isEngagedIn
|
Corporate_Social_Responsibility
|
|
gptkbp:isFocusedOn
|
gptkb:BSE
NSE
|
|
gptkbp:isInvolvedIn
|
Community Engagement
Market Research
Research Collaborations
Partnerships
Product Development
Training Programs
Quality Assurance
Regulatory Affairs
Health Initiatives
Marketing Strategies
Sustainable Practices
Sales Operations
Health Education Programs
Pharmacovigilance
Telemedicine Solutions
Patient Support Programs
Health Policy Advocacy
Global_Health_Initiatives
Supply_Chain_Management
Digital_Health_Solutions
|
|
gptkbp:isKnownFor
|
Quality_Medicines
|
|
gptkbp:isRecognizedFor
|
Innovation
|
|
gptkbp:isSupportedBy
|
Investors
|
|
gptkbp:offersPrograms
|
Generic_Drugs
|
|
gptkbp:operatesIn
|
Pharmaceutical Industry
|
|
gptkbp:providesServices
|
Research_and_Development
|
|
gptkbp:wasFoundedIn
|
1968
|